These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT? Mosquera JM; Fletcher CD Am J Surg Pathol; 2009 Sep; 33(9):1314-21. PubMed ID: 19718788 [TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Miettinen M; Virolainen M; Maarit-Sarlomo-Rikala Am J Surg Pathol; 1995 Feb; 19(2):207-16. PubMed ID: 7530409 [TBL] [Abstract][Full Text] [Related]
24. p63 immunohistochemical staining is limited in soft tissue tumors. Jo VY; Fletcher CD Am J Clin Pathol; 2011 Nov; 136(5):762-6. PubMed ID: 22031315 [TBL] [Abstract][Full Text] [Related]
25. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703 [TBL] [Abstract][Full Text] [Related]
26. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm. Kovarik CL; Hsu MY; Cockerell CJ J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679 [TBL] [Abstract][Full Text] [Related]
27. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070 [TBL] [Abstract][Full Text] [Related]
28. [CD34 detection--an immunohistochemical contribution to differential diagnosis of soft tissue tumors]. Katenkamp D; Mentzel T; Kosmehl H Pathologe; 1996 May; 17(3):195-201. PubMed ID: 8710790 [TBL] [Abstract][Full Text] [Related]
29. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Pelmus M; Guillou L; Hostein I; Sierankowski G; Lussan C; Coindre JM Am J Surg Pathol; 2002 Nov; 26(11):1434-40. PubMed ID: 12409719 [TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669 [TBL] [Abstract][Full Text] [Related]
31. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210 [TBL] [Abstract][Full Text] [Related]
32. Intrarenal solitary fibrous tumor of the kidney report of a case with emphasis on the differential diagnosis in the wide spectrum of monomorphous spindle cell tumors of the kidney. Magro G; Cavallaro V; Torrisi A; Lopes M; Dell'Albani M; Lanzafame S Pathol Res Pract; 2002; 198(1):37-43. PubMed ID: 11866209 [TBL] [Abstract][Full Text] [Related]
33. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children. Shao L; Hill DA; Perlman EJ Pediatr Dev Pathol; 2004; 7(6):577-82. PubMed ID: 15630525 [TBL] [Abstract][Full Text] [Related]
34. [Expression of TEIF protein in soft tissue tumors and its significance]. Gong YL; Li T; Guo H; Sun Y; Chi YK; Ling Y; Shen Q; Liu HJ; Hou L; Zhang B Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):651-5. PubMed ID: 17374207 [TBL] [Abstract][Full Text] [Related]
35. Cytologic features of synovial sarcoma with emphasis on the monophasic fibrous variant: a morphologic and immunocytochemical analysis of bcl-2 protein expression. Viguer JM; Jiménez-Heffernan JA; Vicandi B; López-Ferrer P; Gamallo C Cancer; 1998 Feb; 84(1):50-6. PubMed ID: 9500652 [TBL] [Abstract][Full Text] [Related]
36. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Lazova R; Moynes R; May D; Scott G Cancer; 1997 Jun; 79(11):2115-24. PubMed ID: 9179057 [TBL] [Abstract][Full Text] [Related]
37. Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation. Dickson BC; Riddle ND; Brooks JS; Pasha TL; Zhang PJ Hum Pathol; 2013 Jun; 44(6):1125-30. PubMed ID: 23332867 [TBL] [Abstract][Full Text] [Related]
38. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Mentzel T; Schärer L; Kazakov DV; Michal M Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911 [TBL] [Abstract][Full Text] [Related]
39. Assessment of diagnostic utility of anti-CD34 in soft tissue tumors. Park HR; Park YK J Korean Med Sci; 1995 Dec; 10(6):436-41. PubMed ID: 8924229 [TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of STAT6 in solitary fibrous tumor]. Ding ZY; Wang YF; Wang X; Rao Q Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):235-239. PubMed ID: 28376588 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]